Obstetric Anesthesia Experiences in COVID-19 Positive Patients
Study Details
Study Description
Brief Summary
At the end of 2019, a new coronavirus named COVID-19 (SARS-CoV-2), one of the lower respiratory tract samples was detected in China. The World Health Organization (WHO) declared it a global epidemic on March 11, 2020, due to the emergence of COVID-19 cases in 113 countries other than China, where the first epidemic occurred, and the spread and severity of the virus. Pregnancy increases susceptibility to respiratory complications of viral diseases.
This study aimed to retrospectively evaluate the demographic data of COVID-19 patients undergoing cesarean section, our anesthesia practices, complications, and condition of neonates, and to summarize up-to-date information on COVID-19 in obstetric anesthesia.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Our study was a single-center, retrospective, and observational trial and carried out with the principles of the Declaration of Helsinki. All patient demographics and information about anesthesia were analyzed retrospectively from the patient files.
All patients were operated in negative pressure operating theatres reserved for them. The whole team was equipped with Level 3 personal protective equipment (PPE) (liquid-proof apron, N-95 mask, goggles, visor, overshoes). Anesthesia was administered by 2 healthcare professionals from the anesthesia team, including an experienced anesthesiologist and an assistant anesthesia technician. A third person was kept ready outside to help in case of need.
Study Design
Outcome Measures
Primary Outcome Measures
- obstetric anesthesia practices [until 30 minutes after arrival in the operating room]
the type of anesthesia was investigated
Secondary Outcome Measures
- anesthesia complications [up to 1 hour after anesthesia]
hypotension, nausea, vomiting, allergies
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients who underwent cesarean section
-
Patients who had positive PCR nasopharyngeal swabs for COVID-19
Exclusion Criteria:
- Patients who tested negative and were clinically suspicious
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Health Sciences Turkey, Bursa Yuksek Ihtisas Training and Research Hospital | Bursa | Yıldırım | Turkey | 16290 |
Sponsors and Collaborators
- Turkiye Yuksek Ihtisas Education and Research Hospital
Investigators
- Principal Investigator: Derya Karasu, BursaYuksek Ihtisas Training and Research Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- U1111-1263-2201